Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
312
-
Total 13F shares, excl. options
-
147,667,828
-
Shares change
-
+2,865,335
-
Total reported value, excl. options
-
$10,655,377,287
-
Value change
-
+$238,496,683
-
Put/Call ratio
-
42.13%
-
Number of buys
-
138
-
Number of sells
-
-156
-
Price
-
$72.16
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q3 2014
378 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q3 2014.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 312 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 147,667,828 shares
of 193,539,047 outstanding shares and own 76.3% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (18,021,813 shares), FMR LLC (12,580,811 shares), SANDS CAPITAL MANAGEMENT, LLC (12,098,628 shares), VANGUARD GROUP INC (8,491,038 shares), PRIMECAP MANAGEMENT CO/CA/ (8,043,918 shares), JENNISON ASSOCIATES LLC (5,965,888 shares), State Street Corp (3,958,297 shares), BlackRock Institutional Trust Company, N.A. (3,518,259 shares), WELLS FARGO & COMPANY/MN (2,952,810 shares), and BlackRock Fund Advisors (2,946,908 shares).
This table shows the top 312 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.